Ferring Pharmaceuticals
Clinical trials sponsored by Ferring Pharmaceuticals, explained in plain language.
-
Real-World study of bladder cancer drug adstiladrin ends early
Disease control TerminatedThis study looked at how well the drug Adstiladrin works for bladder cancer when used in regular doctor visits, not just in strict research settings. Researchers planned to follow 202 patients in the US and Israel to see if the drug could make tumors disappear. The study was stop…
Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 13:00 UTC
-
Fertility drug trial halted: could it have boosted IVF success?
Disease control TerminatedThis early-stage trial tested whether adding the drug FE999302 to standard fertility treatment could improve the number of high-quality embryos in women undergoing IVF. The study involved 310 women aged 18-40 with normal ovarian reserve. The trial was terminated early, so results…
Phase: PHASE1 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Infertility drug timing trial halted early
Disease control TerminatedThis early-stage trial aimed to see if giving the drug FE 999302 at different times during fertility treatment could improve the number of good-quality embryos. It involved about 106 women with high ovarian reserve. The study was terminated early, so results are limited.
Phase: PHASE1 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 16:02 UTC